Biochemical aspects of α-L-fucosidase in hepatocellular carcinoma
✍ Scribed by Geneviève Leray; Yves Deugnier; Anne-Marie Jouanolle; Dominique Lehry; Jean-François Bretagne; Jean-Plerre Campion; Pierre Brissot; André Le Treut
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 425 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. Serum ␣-L-fucosidase activity is considered a marker of hepatocellular carcinoma. To the authors' knowledge, its clinical usefulness in the early detection of hepatocellular carcinoma in the follow-up of cirrhotic patients has not been reported previously. ## METHODS. The authors
The authors studied the phenotypic distribution of alpha-L-fucosidase in a random sample of the population of the area of Rennes (France). The frequencies of Fu1 (0.64) and Fu2 (0.36) genes are significantly different from the frequencies observed in New York whites and blacks.
alpha-1-Antitrypsin deficiency due to homozygous Pi ZZ state is reported to be associated with cirrhosis and hepatocellular carcinoma (HCC); however, the role of heterozygous Pi Z state is not definitely known. In order to investigate the possible association, we studied the phenotypic distribution
alpha-L-fucosidase, a lysosomal enzyme which catabolizes fucoproteins, was studied in sera from 30 controls, 32 patients with primary hepatic carcinomas, 24 patients with secondary metastatic liver carcinomas and 36 patients with cirrhosis. Serum alpha-L-fucosidase was increased in primary hepatic c